Home Archives GSK boosted by specialty drugs, end to Zantac fallout GSK boosted by specialty drugs, end to Zantac falloutFebruary 4, 2026 A British pharmaceutical group GSK reported Wednesday a sharp rise in annual net profit, boosted by strong sales of HIV, respiratory and cancer treatments as… Login to continue reading Login Sign up for complimentary access Sign Up Now Close posteditor Articles: 27298 Previous Post UK's ex-prince leaves Windsor home amid Epstein storm: reports Next Post US-Africa trade deal renewal only 'temporary breather'